TOT is a clinical-stage biopharmaceutical company that develops and commercializes novel drugs for the treatment of cancer.
Business Model:
Revenue: $6.5M
Employees: 201-500
Address: No.120 Changyang Street
City: Jiangsu
State: jiangsu province
Zip: 210000
Country: CN
TOT is a clinical-stage biopharmaceutical company that develops and commercializes novel drugs for the treatment of cancer.
Contact Phone:
Contact Email:
Listed Exchange:
Hong Kong Stock Exchange
IPO Date:
11/8/2019
Ticker Symbol:
1875
IPO Price:
$0.8368093927063438/share
Amount Raised:
$75M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2010 | Series A | 1 | $6M |
Chengwei Capital Chengwei Capital |
8/2018 | Series B | 8 | $102M |
99Fund Cathay Capital Center Ventures Chengwei Capital China Universal Asset Management GoldTech Vivo Capital Yuanta Financial Holdings Group 99Fund Cathay Capital Center Ventures Chengwei Capital China Universal Asset Management GoldTech Vivo Capital Yuanta Financial Holdings Group |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|